FDA Inspection
Romark Belgium BVBARomark Belgium BVBA – FDA Inspection, Jun 13, 2014
Record Details
This FDA Inspection record concerns Romark Belgium BVBA, with an inspection on June 13, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Romark Belgium BVBA
- Inspection Date
- June 13, 2014
- Product Type
- Drugs
View Company Profile
ID · 385fd030-64a7-4fd3-aad7-de91286a3afb
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 883655
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Romark Belgium BVBA
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Romark Belgium BVBA
- FDA Inspection 1135007 - 2020-08-14
- FDA Inspection 969503 - 2016-03-17
- FDA Inspection 748191 - 2011-09-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.